Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.
about
Prospects of immune checkpoint modulators in the treatment of glioblastomaEdema is not a reliable diagnostic sign to exclude small brain metastases.Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.Molecular insights into melanoma brain metastases.Correlation of immune phenotype with IDH mutation in diffuse glioma.Histopathologic diagnosis of brain metastases: current trends in management and future considerations.Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.Immune Checkpoint Inhibitors for Brain Metastases.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis.Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic Potential.Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification.World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016The biology and therapeutic management of melanoma brain metastases.Implications of the tumor immune microenvironment for staging and therapeutics.Danger signals: Chemotherapy enhancers?Current markers and their value in the era of immuno-oncology.Clinicopathologic implications of CD8(+)/Foxp3(+) ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients.Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS).Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in IDexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy.Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma.Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease
P2860
Q28081371-817A90B7-DDA9-4383-9FD2-DCD985826F7BQ33663562-1E666DEA-9DD2-4109-8D6D-4D7AD367BDA8Q37267893-D5F90CC7-2B3A-4E60-B9FA-6D688677E187Q37280390-CCC2F47F-7119-4952-AB64-CCE3F98FB4ECQ37584395-5DBB6DD9-FF96-437E-B37F-FFA655EC8C62Q37697218-01785302-24E8-4592-A9F3-0677D3852B86Q38764364-64E36719-A583-4C4B-BD3A-6FE7F271783FQ38771020-410745F1-64CE-4696-8B3C-B3484BCF8CF6Q38791747-91CD42E4-295D-4412-AFD3-ED3378D2107AQ38819190-852F45B0-F2C2-424B-BADE-5A493D4855E4Q39247421-7D38575E-821A-4532-8CD5-7942B3446014Q39313889-95D3A7C7-400A-428E-972D-0030EFA0F0B2Q39583147-570EB86B-E66C-4DF3-9785-014EF521F206Q40582859-52BFA27A-7378-4A6D-AC57-2F9D5BEBCA0EQ40694392-1CCDED4D-6D44-4176-93BA-5E46677BB083Q42053919-AA9980C4-BD65-4EDD-B2F0-E00F70BABCAEQ42396426-DAE8A66C-2386-41D1-B51F-494D6D4F45AAQ42654544-5CE64F57-2A0F-476F-8E71-C9B4D8CA0C41Q47247953-AB5E4573-0E76-475A-BCCF-39C8F0297F95Q47592007-B39CCD45-78CC-4D3B-8CCC-636F9006E42AQ47659090-55254E2E-3E36-4FB6-BB2E-5A6A3E6F147AQ47721195-4AEF317D-35F6-4944-8D11-1E43F85576D0Q47756173-6F4FCE1D-D3CA-44B6-8C24-386B7B78C873Q48164906-07B3E88F-9460-4792-9E5C-CEBB7230C77FQ48307824-050F05A3-078A-4B5D-901B-BF8D27BE34FCQ52604125-BC43AA5F-70F1-42D2-8F65-7D680309DE8BQ52665504-BE7B450B-19FC-4E05-9CE0-B233A1E09E66Q52743918-258B4504-C1F1-4ABF-890E-97E528D456A5Q54685474-BF809BC6-ABA4-4D73-AFE8-8A733BF84213Q55283310-7D5B4E40-80BE-41D3-B3CF-5EF0491D3770Q55513615-69C4A350-F775-4AD1-A639-BF7229B23593Q55709201-C15195C6-3330-44A3-B899-00828083847FQ57490955-139AD443-E399-4A19-89E3-9449E52E624E
P2860
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Density of tumor-infiltrating ...... atients with brain metastases.
@ast
Density of tumor-infiltrating ...... atients with brain metastases.
@en
type
label
Density of tumor-infiltrating ...... atients with brain metastases.
@ast
Density of tumor-infiltrating ...... atients with brain metastases.
@en
prefLabel
Density of tumor-infiltrating ...... atients with brain metastases.
@ast
Density of tumor-infiltrating ...... atients with brain metastases.
@en
P2093
P2860
P50
P1433
P1476
Density of tumor-infiltrating ...... atients with brain metastases.
@en
P2093
Amelie Bilocq
Bernhard Mlecnik
Christoph Zielinski
Daniela Prayer
Elisabeth Fuchs
Gabriela Bindea
Gerda Ricken
Harald Heinzl
Karin Dieckmann
Monika Hackl
P2860
P304
P356
10.1080/2162402X.2015.1057388
P577
2015-06-09T00:00:00Z